Genmab - Stock Price History | GMAB
Historical daily share price chart and data for Genmab since 2023 adjusted for splits. The latest closing stock price for Genmab as of February 03, 2023 is 38.26.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high Genmab stock closing price was 48.72 on September 03, 2021.
- The Genmab 52-week high stock price is 47.50, which is 24.2% above the current share price.
- The Genmab 52-week low stock price is 26.19, which is 31.5% below the current share price.
- The average Genmab stock price for the last 52 weeks is 36.25.
|Genmab Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.